share_log

Illumina | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

Illumina | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

Illumina | S-3ASR：“知名成熟發行人”證券註冊聲明
美股SEC公告 ·  09/04 09:05

Moomoo AI 已提取核心訊息

Illumina, Inc., a global leader in DNA sequencing and array-based technologies, has filed a registration statement with the Securities and Exchange Commission (SEC) on September 4, 2024, for the issuance of various securities, including debt securities, common stock, preferred stock, warrants, stock purchase contracts, stock purchase units, and subscription rights. The registration allows Illumina to offer these securities to the public from time to time, providing the company with financial flexibility for future corporate activities. The securities may be sold through underwriters, dealers, agents, or directly to investors, and the terms will be determined at the time of each offering and detailed in future prospectus supplements. Illumina's common stock is listed on the Nasdaq Global Select Market under the symbol 'ILMN.'
Illumina, Inc., a global leader in DNA sequencing and array-based technologies, has filed a registration statement with the Securities and Exchange Commission (SEC) on September 4, 2024, for the issuance of various securities, including debt securities, common stock, preferred stock, warrants, stock purchase contracts, stock purchase units, and subscription rights. The registration allows Illumina to offer these securities to the public from time to time, providing the company with financial flexibility for future corporate activities. The securities may be sold through underwriters, dealers, agents, or directly to investors, and the terms will be determined at the time of each offering and detailed in future prospectus supplements. Illumina's common stock is listed on the Nasdaq Global Select Market under the symbol 'ILMN.'
全球貨幣Illumina公司，DNA測序和基於陣列技術領域的全球領導者，已於2024年9月4日向美國證券交易委員會（SEC）提交了一份註冊聲明，用於發行各種證券，包括債務證券、普通股、優先股、warrants、股票購買合同、股票購買單位和認購權。註冊允許Illumina隨時向公衆提供這些證券，爲未來的企業活動提供財務靈活性。證券可以通過承銷商、經銷商、代理商或直接向投資者出售，每一次發行的條款將在未來的招股書補充中確定並詳細說明。Illumina的普通股在納斯達克全球精選市場上的標的是'ILMN'。
全球貨幣Illumina公司，DNA測序和基於陣列技術領域的全球領導者，已於2024年9月4日向美國證券交易委員會（SEC）提交了一份註冊聲明，用於發行各種證券，包括債務證券、普通股、優先股、warrants、股票購買合同、股票購買單位和認購權。註冊允許Illumina隨時向公衆提供這些證券，爲未來的企業活動提供財務靈活性。證券可以通過承銷商、經銷商、代理商或直接向投資者出售，每一次發行的條款將在未來的招股書補充中確定並詳細說明。Illumina的普通股在納斯達克全球精選市場上的標的是'ILMN'。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

獨立文件3  查看翻譯

獨立文件4  查看翻譯

獨立文件5  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間